Vaccines in Renal Cell Carcinoma: A Lost Cause or the Way Forward?

Tian Zhang, MD, Duke Cancer Institute, Duke University Medical Center presents “Vaccines in Renal Cell Carcinoma: A Lost Cause or the Way Forward?” at the 2016 annual International Kidney Cancer Symposium.

Vaccines in Renal Cell Carcinoma: A Lost Cause or the Way Forward?

Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani

Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD

FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

Vaccines in Renal Cell Carcinoma: A Lost Cause or the Way Forward?

Related Posts

Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani

Advances in Acute Lymphoblastic Leukemia (ALL) Treatment: A Focus on Targeted Therapies – Elias Jabbour, MD

FDA grants accelerated approval to ponatinib (ICLUSIG®) with chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia